In this interview with Andrew Kleuss on Investors Hub, Vitaliy makes the case that concerns over Amazon’s entry into the pharmaceuticals business are probably overblown. To parse this problem, Vitaliy differentiates between pharmacies and drug distributors, and analyzes the extent to which Amazon can compete with both. While Amazon might place some pressure on pharmacies over time, he explains how drug distributors’ unique supply chains should remain robust against a competitive threat from Amazon.
New to investing?
Explore these valuable guides to get started.
Related Articles
Your Sophist Filter: On CEOs, Cynics, and the Voice in Your Head – Ep 304
A great speaker can bend logic with emotions and exert undue influence on your decision making. The better someone speaks, the more discriminating your Sophist filter needs to be.
My New Daughter – Ep 303
The Wedding Politburo gave me three minutes for this speech, as its members are still suffering from PTSD from my last one, which ran 50. Okay, I'll keep this one to 40.
Depressing Reasons Why I Am Bullish On Gold (Part 2) – Ep 302
Here is what changed my mind. Not something about gold, but many things about the dollar. The US dollar is the world's reserve currency. It has had a well-deserved place since WWII, and that rested on three things: the largest, steadiest, most diverse economy; a politically stable democracy; the best military.
Narrative Change (Part 1) – Ep 301
Narrative change is a reversal of mass behavior. Economics and stock market valuation are governed by soft laws, but the reality bent by human behavior can disagree with these soft laws for much longer than rational actors would expect, or stay solvent. The change, going from euphoria to despair, is a change in narrative.
comments
0